Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Olivier Bylicki"'
Autor:
Elodie Valero-Biance, Frédéric Janvier, Audrey Ferrier, Antoine Bronstein, Olivier Ferraris, Carine Malle, Olivier Bylicki, Jean-Nicolas Tournier, A. Mayet, Anne Perisse, David Delarbre, Jacques Cobola, Nastasia Menoud
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Elsevier, 2021, 112, pp.8-12. ⟨10.1016/j.ijid.2021.09.002⟩
International Journal of Infectious Diseases, Vol 112, Iss, Pp 8-12 (2021)
International Journal of Infectious Diseases, 2021, 112, pp.8-12. ⟨10.1016/j.ijid.2021.09.002⟩
International Journal of Infectious Diseases, Elsevier, 2021, 112, pp.8-12. ⟨10.1016/j.ijid.2021.09.002⟩
International Journal of Infectious Diseases, Vol 112, Iss, Pp 8-12 (2021)
International Journal of Infectious Diseases, 2021, 112, pp.8-12. ⟨10.1016/j.ijid.2021.09.002⟩
International audience; Objective: A better understanding of the immune response against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is critical to predict its dynamics within the general population and its impact on the va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78568a3c3a8419a664f17add08bd4944
https://www.hal.inserm.fr/inserm-03651036/document
https://www.hal.inserm.fr/inserm-03651036/document
Autor:
Audrey Mérens, Christophe Renard, Anne Margaux Legland, Julie Plantamura, Olivier Bylicki, Marie Pierre Otto, Eric Garnotel, Aurore Bousquet, Frédéric Janvier, Hervé Delacour, Elodie Valero, Christine Bigaillon, Vincent Foissaud, P. Vest, Catherine Verret, Solenne Martin, Hélène Astier
Publikováno v:
European Journal of Clinical Microbiology and Infectious Diseases
European Journal of Clinical Microbiology and Infectious Diseases, 2021, 40 (10), pp.2191-2198. ⟨10.1007/s10096-021-04269-4⟩
European Journal of Clinical Microbiology and Infectious Diseases, 2021, 40 (10), pp.2191-2198. ⟨10.1007/s10096-021-04269-4⟩
Molecular diagnosis on nasopharyngeal swabs (NPS) is the current standard for COVID-19 diagnosis, but saliva may be an alternative specimen to facilitate access to diagnosis. We compared analytic performances, feasibility and acceptability of NPS, sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ec0b034dbd2ea36d967e2c92258afa
https://amu.hal.science/hal-03666284
https://amu.hal.science/hal-03666284
Autor:
Isabelle, Martel-Lafay, Isabelle, Monnet, Audrey, Lardy-Cleaud, Serge, Danhier, Naji, Salem, Olivier, Gallocher, Pierre, Fournel, Christos, Chouaid, Olivier, Bylicki, The Gfpc-Investigators
Publikováno v:
Current Oncology
Volume 28
Issue 5
Pages 324-3811
Current Oncology, Vol 28, Iss 324, Pp 3804-3811 (2021)
Volume 28
Issue 5
Pages 324-3811
Current Oncology, Vol 28, Iss 324, Pp 3804-3811 (2021)
Concomitant radiochemotherapy (RTCT) is the standard treatment for unresectable stage III non-small cell lung cancer (NSCLC). However, in patients with a peripheral primary tumor, the irradiated volume may include a large portion of normal lung and R
Autor:
Gilles Robinet, Christos Chouaid, Radj Gervais, Roland Schott, Florian Guisier, Chantal Decroisette, Jean-Bernard Auliac, Olivier Bylicki, Charles Ricordel, Laurent Greillier, Maurice Pérol, Benjamin Besse, Renaud Descourt
Publikováno v:
Future Oncology
Future Oncology, 2021, 17 (23), pp.3007-3016. ⟨10.2217/fon-2020-1202⟩
Future Oncology, 2021, 17 (23), pp.3007-3016. ⟨10.2217/fon-2020-1202⟩
Pembrolizumab plus chemotherapy is currently used in the first-line treatment of advanced non-small-cell lung cancer withoutLay abstract Non-small-cell lung cancer (NSCLC) is the most frequent type of lung cancer. Most NSCLC patients are diagnosed wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62d4948a536b358f6ce91b90b9bc53c5
https://inria.hal.science/hal-03526346
https://inria.hal.science/hal-03526346
Publikováno v:
Expert review of anticancer therapy. 21(10)
Introduction: Despite recent therapeutic advances, lung cancer remains the primary cause of cancer deaths worldwide, and early lung mortality was poorly studied.Area covered: Early lung-cancer mort...
Publikováno v:
The New England journal of medicine. 384(10)
Publikováno v:
Anaesthesia Critical Care & Pain Medicine. 38:661-663
Autor:
Olivier Bylicki, Francois-Xavier Brocq, Bertrand Dautzenberg, Hélène Barazzutti, Vanessa Marbac, Frédéric Janvier, A. Mayet, Nicolas Paleiron, Anne Perisse
Publikováno v:
Nicotine & Tobacco Research
Nicotine and Tobacco Research
Nicotine and Tobacco Research, Oxford University Press (OUP), 2022, 23 (8), pp.1398-1404. ⟨10.1093/ntr/ntab004⟩
Nicotine and Tobacco Research
Nicotine and Tobacco Research, Oxford University Press (OUP), 2022, 23 (8), pp.1398-1404. ⟨10.1093/ntr/ntab004⟩
Introduction Preliminary reports indicated that smokers could be less susceptible to coronavirus SARS-CoV-2, which causes Covid-19. However, once infected an increased risk of severe disease is reported. We investigated the association between smokin
Publikováno v:
Haematologica
Autor:
Frédéric Janvier, Hélène Barazzutti, Vanessa Marbac, Olivier Bylicki, Bertrand Dautzenberg, A. Mayet, Nicolas Paleiron, Anne Perisse, Francois-Xavier Brocq
Publikováno v:
SSRN Electronic Journal.
BACKGROUND: Preliminary reports indicated that smokers could be less susceptible to the coronavirus SARS-CoV-2, which causes Covid-19. However, once infected, smokers are at risk of severe disease. This epidemiologic finding could have highly relevan